Back to company

Speciallægeselskabet Hjerne- og Nerveklinikken ApS: Financial statements 2024

CVR: 39082071

Speciallægeselskabet Hjerne- og Nerveklinikken ApS (CVR 39082071) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,600,578 and a net result of DKK 706,342 compared with DKK 445,038 the year before. That is an increase of 12.1% compared with the year before. Equity amounted to DKK 1,456,356. The solvency ratio was 80.1%. The company had 2 employees in the financial year.

Gross Profit
2,600,578 kr.
Profit/Loss
706,342 kr.
Equity
1,456,356 kr.
Total Assets
1,817,251 kr.
Employees
2

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.6 mio.706 t.1.5 mio.2
2023-2.3 mio.445 t.1.2 mio.2
2022-1.9 mio.495 t.1 mio.2
2021-2 mio.492 t.625 t.2
2020-2 mio.303 t.733 t.2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Speciallægeselskabet Hjerne- og Nerveklinikken ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

Speciallægeselskabet Hjerne- og Nerveklinikken ApS: The 2023 annual report is outMar 19, 2024

Speciallægeselskabet Hjerne- og Nerveklinikken ApS has published its annual report for 2023. Gross profit came to DKK 2,320,673, and the net result was DKK 445,038.

About Speciallægeselskabet Hjerne- og Nerveklinikken ApS

Speciallægeselskabet Hjerne- og Nerveklinikken ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Speciallægers aktiviteter. The management consists of Linda Jansons Locht. The company is owned by Linda Jansons Locht. The company has 2 employees. In 2025, the company reported a gross profit of DKK 2,582,645 and a net result of DKK 871,392 compared with DKK 706,342 the year before. Equity amounted to DKK 927,748.

Other financial years